Fig. 3From: Comparing syngeneic and autochthonous models of breast cancer to identify tumor immune components that correlate with response to immunotherapy in breast cancerT cell immune subsets differ significantly between the different versions of the MMTV-PyMT breast tumor model. Tumors from the autochthonous MMTV-PyMT model were harvested and single-cell suspensions were generated. Cells (1E6, 1E5, or 1E4) were injected into the mammary fat pad of FVB/NJ wild-type mice. When the tumors reached 100 mm3, tumors were obtained and processed into a single-cell suspension for immunophenotyping by flow cytometry. a–d Analysis of T cell subsets as a percent of CD3+ cells and include: a T-regulatory cells (FoxP3+CD4+), b FoxP3-CD4+, c CD8+, and d other CD3+ cells. e Analysis of lymphocyte cell subsets as a percent of viable cells represented as pie charts. f The ratio of CD4+ to CD8+ out of total lymphocytes. g Analysis of T regulatory cells represented by FoxP3+ of CD4+ cells. h The ratio of CTLs represented by GZB+ of CD8+. i The ratio of CTLs to T-regulatory cells. Graphs show mean ± SEM from at least two independent experiments with at least three mice per group. Each data point represents an individual mouse. Unpaired two-tailed t test. *P<0.05, **P<0.01, ***P<0.001, and ****P<0.001Back to article page